SE9901961D0 - Fimbrial proteins - Google Patents

Fimbrial proteins

Info

Publication number
SE9901961D0
SE9901961D0 SE9901961A SE9901961A SE9901961D0 SE 9901961 D0 SE9901961 D0 SE 9901961D0 SE 9901961 A SE9901961 A SE 9901961A SE 9901961 A SE9901961 A SE 9901961A SE 9901961 D0 SE9901961 D0 SE 9901961D0
Authority
SE
Sweden
Prior art keywords
subspecies
salmonella enterica
fimbrial proteins
fimbrial
proteins
Prior art date
Application number
SE9901961A
Other languages
English (en)
Inventor
Anders Folkesson
Staffan Normark
Sven Loefdahl
Original Assignee
Anders Folkesson
Staffan Normark
Sven Loefdahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Folkesson, Staffan Normark, Sven Loefdahl filed Critical Anders Folkesson
Priority to SE9901961A priority Critical patent/SE9901961D0/sv
Publication of SE9901961D0 publication Critical patent/SE9901961D0/sv
Priority to PCT/SE2000/001079 priority patent/WO2000073336A1/en
Priority to AU52628/00A priority patent/AU773484B2/en
Priority to JP2001500660A priority patent/JP2003502291A/ja
Priority to CA002372250A priority patent/CA2372250A1/en
Priority to NZ515912A priority patent/NZ515912A/xx
Priority to EP00937458A priority patent/EP1180118A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9901961A 1999-05-28 1999-05-28 Fimbrial proteins SE9901961D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9901961A SE9901961D0 (sv) 1999-05-28 1999-05-28 Fimbrial proteins
PCT/SE2000/001079 WO2000073336A1 (en) 1999-05-28 2000-05-26 Fimbrial proteins
AU52628/00A AU773484B2 (en) 1999-05-28 2000-05-26 Fimbrial proteins
JP2001500660A JP2003502291A (ja) 1999-05-28 2000-05-26 線毛タンパク質
CA002372250A CA2372250A1 (en) 1999-05-28 2000-05-26 Fimbrial proteins
NZ515912A NZ515912A (en) 1999-05-28 2000-05-26 Fimbrial proteins
EP00937458A EP1180118A1 (en) 1999-05-28 2000-05-26 Fimbrial proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901961A SE9901961D0 (sv) 1999-05-28 1999-05-28 Fimbrial proteins

Publications (1)

Publication Number Publication Date
SE9901961D0 true SE9901961D0 (sv) 1999-05-28

Family

ID=20415789

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901961A SE9901961D0 (sv) 1999-05-28 1999-05-28 Fimbrial proteins

Country Status (7)

Country Link
EP (1) EP1180118A1 (sv)
JP (1) JP2003502291A (sv)
AU (1) AU773484B2 (sv)
CA (1) CA2372250A1 (sv)
NZ (1) NZ515912A (sv)
SE (1) SE9901961D0 (sv)
WO (1) WO2000073336A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092814A2 (en) * 2001-05-17 2002-11-21 Creatogen Aktiengesellschaft Screening method for attenuating or virulence defective microbial cells
JP2011521665A (ja) 2008-06-03 2011-07-28 ヘルス プロテクション エージェンシー サルモネラ検出アッセイ

Also Published As

Publication number Publication date
AU773484B2 (en) 2004-05-27
WO2000073336A1 (en) 2000-12-07
AU5262800A (en) 2000-12-18
CA2372250A1 (en) 2000-12-07
NZ515912A (en) 2004-02-27
JP2003502291A (ja) 2003-01-21
EP1180118A1 (en) 2002-02-20

Similar Documents

Publication Publication Date Title
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
EA200201214A1 (ru) Замещенные тиоацетамиды
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
HRP941000B9 (hr) Morfolin i tiomorfolin antagonisti receptora tahikinina
NO20025590D0 (no) Fenylglycin-derivater
SE7713721L (sv) Substituerade acylderivat av aminosyror
BR0014470A (pt) Inibidores de fab i
CY1113312T1 (el) Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
TR200201004T2 (tr) Monoamin reuptake önleyicileri olarak biaril eter türevleri
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
CY1105097T1 (el) Χρηση παραγωγων ν-φαινυλο-2-πυριμιδιναμινης στην αγωγη εναντι φλεγμονωδων ασθενειων
NO20005672L (no) Svekkede Salmonella-mutanter som konstitutivt uttrykker Vi- antigenet
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
CY1106133T1 (el) Αγωνιστες υποδοχεα 2 παραγοντα απελευθερωσης κορτικοτροπινης
BG107220A (en) Antitumoral ecteinascudin derivatives
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
EA200200876A1 (ru) Алкилированные производные имидазопиридина
EA200200875A1 (ru) Пролекарства производных имидазопиридина
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
DK1242410T3 (da) Nye forbindelser
CY1105345T1 (el) Φαινυλαλκινια
SE9903290D0 (sv) Novel compounds
ATE361363T1 (de) Impfstoff, der peroxiredoxin enthält